Friday, April 20, 2018 6:51:36 PM
Check out our previous distributor for Nyloxin (then called Cobroxin) product in 2009 / 2010:
At the time, the product was in CVS, Walgreens, and many other retail brick and mortor stores... However, due to a breach of contract by the distributor, Nutrapharma severed the relationship in 2011... and yes, at the time, the distributor was new to business with few employees.... but nonetheless, Nutrapharma stock was trading at $1 with a market cap of 220 million <adjusted for the 1/40 stock split on 05/18/15>... execution trumps time on the job any day... refer to Bill Gates, Steve Jobs, and Mark Zukkenburg as examples.
However, once the gsa approves and more retail contracts are established this market cap will seem marginal VERY SOON!!!... add in the mix any announcement of a JV partnership and the pursuit of more clinical trials and our stock price could be multi dimes / quarters EVEN SOONER!
...and here we sit at approximately a market cap of 50Xs less than previous years with hundreds of times more potential.
Xenacare distributor
Cobroxin in Walgreens
Cobroxin in CVS
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM